Roche Holding Financials

Roche Holding Stock Summary

Roche Holding competes with AstraZeneca PLC, Roche Holding, Roche Holding, Grifols SA, and Novartis. Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Hld operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 100920 people.

Roche Holding Key Financial Ratios

There are many critical financial ratios that Roche Holding's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Roche Holding AG reports annually and quarterly.

Roche Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Roche Holding's current stock value. Our valuation model uses many indicators to compare Roche Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Roche Holding competition to find correlations between indicators driving Roche Holding's intrinsic value. More Info.Roche Holding AG is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.33  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Roche Holding AG is roughly  3.05 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Roche Holding's earnings, one of the primary drivers of an investment's value.

Roche Holding AG Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Roche Holding help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Roche Holding AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Roche Holding AG based on widely used predictive technical indicators. In general, we focus on analyzing Roche OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Roche Holding's daily price indicators and compare them against related drivers.

When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.